- Home
- LFVN vs OPTN Comparison
LFVN vs OPTN Comparison
Compare LFVN & OPTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LFVN
- OPTN
- Stock Information
- Founded
- LFVN N/A
- OPTN 2010
- Country
- LFVN United States
- OPTN United States
- Employees
- LFVN N/A
- OPTN N/A
- Industry
- LFVN Biotechnology: Pharmaceutical Preparations
- OPTN Biotechnology: Pharmaceutical Preparations
- Sector
- LFVN Health Care
- OPTN Health Care
- Exchange
- LFVN Nasdaq
- OPTN Nasdaq
- Market Cap
- LFVN 127.0M
- OPTN 99.7M
- IPO Year
- LFVN N/A
- OPTN 2017
- Fundamental
- Price
- LFVN $12.15
- OPTN $0.67
- Analyst Decision
- LFVN
- OPTN Strong Buy
- Analyst Count
- LFVN 0
- OPTN 2
- Target Price
- LFVN N/A
- OPTN $4.00
- AVG Volume (30 Days)
- LFVN 93.5K
- OPTN 487.4K
- Earning Date
- LFVN 11-07-2024
- OPTN 11-07-2024
- Dividend Yield
- LFVN 1.32%
- OPTN N/A
- EPS Growth
- LFVN 15.00
- OPTN N/A
- EPS
- LFVN 0.23
- OPTN N/A
- Revenue
- LFVN $200,164,000.00
- OPTN $75,058,000.00
- Revenue This Year
- LFVN $4.36
- OPTN $24.44
- Revenue Next Year
- LFVN $3.85
- OPTN $49.00
- P/E Ratio
- LFVN $52.83
- OPTN N/A
- Revenue Growth
- LFVN N/A
- OPTN 3.91
- 52 Week Low
- LFVN $4.20
- OPTN $0.65
- 52 Week High
- LFVN $13.71
- OPTN $2.10
- Technical
- Relative Strength Index (RSI)
- LFVN 61.51
- OPTN 32.09
- Support Level
- LFVN $11.88
- OPTN $0.65
- Resistance Level
- LFVN $12.68
- OPTN $0.74
- Average True Range (ATR)
- LFVN 0.81
- OPTN 0.04
- MACD
- LFVN -0.08
- OPTN 0.00
- Stochastic Oscillator
- LFVN 51.40
- OPTN 20.00
About LFVN Lifevantage Corporation (Delaware)
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system, as well as Canine Health, a companion pet supplement formulated to combat oxidative stress in dogs. Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.
About OPTN OptiNose Inc.
OptiNose Inc is a specialty pharmaceutical company that focuses on the development and commercialization of products for patients treated by ear, nose, and throat, and allergy specialists. Its product includes XHANCE (fluticasone propionate) nasal spray, 93 micrograms, a therapeutic utilizing its proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. The XHANCE is able to deliver medication to the primary site of inflammation high and deep in the nasal passages in regions not adequately reached by intranasal steroids.